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2 The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USAPhotoacoustic tomography (PAT) is an attractive modality for noninvasive, volumetric imaging of
scattering media such as biological tissues. By choosing the ultrasonic detection frequency, PAT enables
scalable spatial resolution with an imaging depth of up to 7 cm while maintaining a high depth-to-
resolution ratio of 200 and consistent optical absorption contrasts. Photoacoustic microscopy (PAM),
the microscopic embodiment of PAT, aims to image at millimeter depth and micrometer-scale
resolution. PAM is well-suited for characterizing three-dimensional scaffold-based samples, including
scaffolds themselves, cells, and blood vessels, both qualitatively and quantitatively. Here we review our
previous work on applications of PAM in tissue engineering and then discuss its future developments.Introduction
Tissue engineering is an interdisciplinary, rapidly developing field
that deals with the development of new tissue/organ substitutes to
promote the healing or replacement of injured tissues [1–3]. In
most cases, three-dimensional (3D) scaffolds are required to play a
vital role in providing physical support and a controllable micro-
environment for desired cell activity and tissue growth [4–7]. To
optimize its performance in the regeneration of a specific tissue,
the scaffold must possess appropriate properties, such as biocom-
patibility, biodegradability, tissue-matching mechanical strength,
as well as proper porosity, pore size, and interconnectivity [8,9]. To
this end, it is of great importance to examine, monitor, and
quantitatively assess cell attachment, migration, proliferation,
differentiation, and tissue formation within the scaffolds. In addi-
tion, there is also a strong need to monitor the alterations to the
scaffolds themselves, such as changes in porosity, pore size, and
degradation [10,11].
Despite many years of research, it remains a challenge to visua-
lize the inside of scaffolds at high spatial resolution, deep pene-
tration, and strong contrast in a non-invasive manner. The most
widely used imaging modalities to characterize scaffold/tissue
constructs include X-ray micro-computed tomography (micro-
CT), scanning electron microscopy (SEM), laser-scanning optical*Corresponding authors: Xia, Y. (younan.xia@bme.gatech.edu),
Wang, L.V. (lhwang@wustl.edu)
1369-7021/06 2013 Elsevier Ltd. http://dx.doi.org/10.1016/j.mattod.201Open access under CC BY-NC-ND license.
 microscopy (LSM), optical coherence tomography (OCT), and
magnetic resonance imaging (MRI). Micro-CT can penetrate the
entire thickness of a scaffold/tissue construct up to several cen-
timeters. However, the capability of micro-CT is limited by poor
contrast for soft tissues and fluid-perfused scaffolds [12], unless a
toxic contrast agent (e.g. osmium tetroxide) is administered [13–
15]. SEM can provide fine resolution up to a few nanometers, but
the penetration depth is essentially limited to the surface. In
addition, it is invasive and requires dehydration and fixation of
the biological samples such as cells and the extracellular matrix
(ECM) [16]. Additionally, both micro-CT and SEM are based on
ionizing irradiation that poses hazards to organisms. LSM, includ-
ing confocal andmulti-photonmicroscopy, has long been used for
visualizing cells and angiogenesis in scaffolds [17,18]. However,
because of strong light scattering, especially in the presence of
blood, LSM has a limited tissue penetration of several hundred
micrometers, and it also requires a fluorescent chromophore as the
probe [19]. OCT has been demonstrated for label-free imaging of
tissue/scaffold constructs at a relatively high resolution (0.9 mm)
[20], but it is rather difficult to distinguish the tissue and the
scaffold in a sample because of their similar refractive indices. MRI
has been employed to identify the deposition of ECM secreted by
cells in scaffolds in vivo [21], and can be potentially used to
evaluate cell differentiation [22]. Nevertheless, MRI suffers from
relatively low spatial resolution (70–100 mm) and long image
acquisition time. Therefore, new imaging techniques with high3.03.007 67
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FIGURE 1
Schematic of OR-PAM. The solid boundary inset at the bottom center shows the configuration of the acoustic-optical combiner in G1 OR-PAM. BS, beam
splitter; CCD, charge-coupled device; ConL, condenser lens; CorL, correction lens; FC, fiber collimator; ND, neutral density; PD, photodiode; RAP, right-angle
prism; RhP, rhomboid prism; SMF, single-mode fiber; SO, silicone oil; US, ultrasonic transducer.
Reprinted with permission from Ref. [44]. Copyright 2011 Optical Society of America.
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needed to allow for non-invasive imaging and monitoring of
volumetric information of 3D scaffold-based samples.
Photoacoustic tomography (PAT) is a new and potent imaging
modality, which relies on the collection of photoacoustic signals
[(Figure_2)TD$FIG]
FIGURE 2
Experimental dark-field confocal AR-PAM system.
Reprinted with permission from Ref. [37]. Copyright 2006 Nature Publishing Grou
68generated from absorbed laser irradiation [23–27]. PAT breaks
through the optical diffusion limit and provides imaging depths
up to 7 cm [23]. By tuning the ultrasonic detection frequency,
PAT enables scalable high-resolution imaging of biological struc-
tures with strong optical absorption contrasts [28]. In the pastp.
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animals [29–32] and humans [33–36]. PAT systems have three
major types: photoacoustic microscopy (PAM) [37], photoacoustic
computed tomography (PACT) [38], and photoacoustic endoscopy
(PAE) [39]. Among them, PAM uses direct point by point detection
and raster scanning to generate an image.
In this review, we focus on PAMof 3D scaffolds or scaffold/tissue
constructs for tissue engineering and regenerative medicine. We
first introduce the fundamentals of PAM. Next, we highlight our
previous work, which was essentially the first ensemble of applica-
tions of PAM in tissue engineering, including characterization of
the properties of a porous scaffold, resolution of the spatial dis-
tribution of cells in a scaffold, and monitoring of the invasion of
neovasculature into scaffolds, together with quantitative analyses
in all cases. Finally, we point out some remaining issues and
envision a few possible future developments.
Fundamentals of photoacoustic microscopy
In PAM, both the optical excitation and the ultrasonic detection are
focused. The foci are configured coaxially and confocally. The laser
fluence on tissue surface could bemaintainedwell below or close to
the American National Standards Institute (ANSI) safety limit [40].[(Figure_3)TD$FIG]
FIGURE 3
(a) An optical microscopy image of a porous PLGA scaffold incorporated with SW
image of the scaffold acquired by OR-PAM. Note that matching features can be i
a small pore; ES, the edge of scaffold). (d) A 3D reconstruction image of the OR-
Reprinted with permission from Ref. [12]. Copyright 2011 Mary Ann Liebert, Inc.For each laser shot, time-resolved ultrasonic detection produces a
one-dimensional (1D), depth-resolved image (A-line) without
mechanical scanning. Thus, a 1D line scanning produces a two-
dimensional (2D) frame (B-scan) and a 2D raster scanning along the
transverse plane produces complete volumetric (3D) information.
Volumetric images can be viewed through either maximum ampli-
tude projection (MAP) or direct 3D rendering. MAP is typically
performed by projecting themaximum signal amplitude from each
A-line onto the transverse plane, although projections along other
axes are possible as well. Usually, PAM aims to image millimeters
deep at micrometer-scale resolution. The axial resolution and the
maximum penetration depth are inversely proportional to the
central frequency of the ultrasonic transducer [41]. The axial resolu-
tion is on the scale of 10 mm [42,43], which is sufficient for most
tissue engineering applications at the cellular level. It becomes
inadequate onlywhen subcellular resolution is required for applica-
tions in cell biology. The lateral resolution is predominantly deter-
minedby the tighter focus of the dual foci. This, in turn, canbe used
to further classify PAM into optical-resolution PAM (OR-PAM)
[44,45] and acoustic-resolution PAM (AR-PAM) [37].
In OR-PAM (Fig. 1), a bright-field optical illumination, with a
much tighter focus than the acoustic focus, is adopted to achieveNTs. (b) An MAP image of the scaffold acquired by AR-PAM. (c) An MAP
dentified in these images (indicated by labeled arrows: LP, a large pore; SP,
PAM data.
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microscope objective to achieve optical focusing. A right-angle
prism and a rhomboid prism sandwich a thin layer of silicone oil
for acoustic-optical coaxial and confocal alignment. The interface
between the prism glass and silicone oil provides optical transmis-
sion but acoustic reflection because of the matched optical refrac-
tive indices but mismatched acoustic impedances. A correction
lens attached to the top surface of the right-angle prism is used to
compensate for the optical aberration. OR-PAM provides lateral
resolution ranging from a few hundred nanometers to a few
micrometers, sufficient to resolve single cells or even subcellular
structures [46–48]. However, the tissue penetration of OR-PAM is
restricted to less than 1.2 mm because of the high optical scatter-
ing [44]. Although the imaging depth of OR-PAM is limited to the
ballistic photon regime as that of pure optical microscopy, OR-
PAM provides primarily optical absorption contrasts instead of
conventional optical scattering or fluorescence contrasts.
In AR-PAM (Fig. 2), the optical focus is much wider than
the ultrasonic focus and it is implemented through a dark-field[(Figure_4)TD$FIG]FIGURE 4
(a) A transmission optical microscopy image showing the melanoma cells grown
showing individual melanoma cells or a cluster of melanoma cells grown in indiv
MAP images. The black dots or patches correspond to melanoma cells. (e) A 3D
dotted lines.
Reprinted with permission from Ref. [65]. Copyright 2010 Elsevier.
70illumination. The light is reshaped by a conical lens to form a ring
pattern [37,49]. The ring-shaped light is then weakly focused into
the sample by an optical condenser. The generated photoacoustic
waves are detected by a focused ultrasound transducer, which is
located in the center of the optical condenser. Using an ultrasound
transducer with a central frequency of 50 MHz, AR-PAM achieves a
lateral resolution of 45 mm, an axial resolution of 15 mm, and a
penetration depth of more than 3 mm [37]. In this depth range,
the resolution is determined by ultrasonic detection because ultra-
sound scattering is much weaker than optical scattering in biolo-
gical tissues and polymer scaffolds [50].
Photoacoustic microscopy characterization of porous
scaffolds
It is important to characterize the properties of porous scaffolds – a
critical component in tissue engineering – such as the porosity,
pore size, and material degradation, in an effort to optimize their
use in different applications. While conventional, destructive
methods (e.g. SEM) are still widely used, a few techniques basedin a PLGA inverse opal scaffold for 14 days. (b and c) SEM images
idual pores of a scaffold. (d) PAM coronal (top) and sagittal (side)
reconstruction image, where the contour of the scaffold is marked by
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however, largely suffer from the aforementioned limitations.
Therefore, PAM has come into attention in fulfilling this job. In
a recent demonstration, both OR-PAM [44] and AR-PAM [37] were
employed to image and characterize poly(D,L-lactide-co-glycolide)
(PLGA) scaffolds incorporated with single-walled carbon nano-
tubes (SWNTs) [55].
Fig. 3a shows an optical micrograph of the scaffold. A small
quantity of SWNTs was introduced into the PLGA matrix to
enhance the photoacoustic contrast from the scaffold [56,57],
because PLGA itself could not generate sufficient photoacoustic
signals to achieve sufficient contrast at the experimental wave-
lengths. Fig. 3b and c shows MAP images of the scaffold
obtained by AR-PAM and OR-PAM, respectively, at an excitation
wavelength of 570 nm. Fig. 3d shows a 3D depiction of the
scaffold acquired by OR-PAM. The images of the scaffold
obtained from PAM show clear details of the structure, which
agree well with those obtained from optical microscopy. The
common features that can be identified from the images are
indicated by arrows (LP, a large pore; SP, a small pore; ES, the
edge of scaffold). For this type of scaffold, AR-PAM and OR-PAM
provided penetration depths of 1.7 mm and 660 mm, respec-
tively. Thus, using PAM, a 3D scaffold can be conveniently and
nondestructively examined to measure physical properties such
as pore size and porosity.[(Figure_5)TD$FIG]
FIGURE 5
MAP PAM images of melanoma cells in a scaffold cultured for 14 days. The imag
slicing the scaffold. The first layer started at 420 mm beneath the surface, and th
Reprinted with permission from Ref. [65]. Copyright 2010 Elsevier.The capability of PAM to resolve scaffolds under physiological
conditions was demonstrated by imaging the SWNT-incorporated-
scaffold either immersed in bovine blood or embedded in chicken
tissue. According to the optical absorption spectra of SWNTs and
blood [58,59], twowavelengths (570 nm and 638 nm)were chosen
to spectrally differentiate the photoacoustic signals generated
from blood and from the SWNT-incorporated scaffold. Under
these simulated physiological conditions, OR-PAM was defocused
to image a small portion of the scaffold at superficial depth,
whereas AR-PAM was still able to penetrate the tissue/blood-cov-
ered scaffold to a depth of 1.7 mm.
PAM was further used to quantify the porosity and pore size of
the SWNT-incorporated-scaffolds. For OR-PAM, the porosity and
pore size of the scaffolds were estimated to be 86.5%  1.2% and
153  15 mm (average diameter  standard error, n = 4), respec-
tively. And for AR-PAM, the porosity and pore size were
81.8%  4.4% and 167  24 mm, respectively. These results agreed
well with each other and with those measured by micro-CT
(88.6%  0.8% and 145  9 mm).
Photoacoustic microscopy imaging of living cells in
porous scaffolds
Melanoma cells in scaffolds
Because melanoma cells contain naturally dark pigments, they
exhibit strong intrinsic contrast for label-free PAM with highes were taken from different layers parallel to the top surface without
e layer spacing was 60 mm.
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FIGURE 6
(a) Time course PAM images (coronal MAP of the entire volume) of
melanoma cells in a typical PLGA inverse opal scaffold at 1, 3, 7 and 14
days post-seeding. (b) Quantitative analysis of melanoma cells in scaffolds
derived from both the PAM volumetric data (n = 4) and the MTT assay
(n = 3). The data are presented as mean  standard error.
Reprinted with permission from Ref. [65]. Copyright 2010 Elsevier.
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system was employed to image melanoma cells seeded in PLGA
inverse opal scaffolds [63,64] for tissue engineering applications
[65]. The inverse opal scaffolds represent a unique type of 3D
porous scaffolds that have uniform pore sizes and a long-range
ordered pore structure. These features can provide good intercon-
nectivity throughout the entire scaffold to facilitate cell migration
and nutrient/waste transport [9,66–68].
Fig. 4a–c shows the morphology of melanoma cells in PLGA
inverse opal scaffolds. Under an optical microscope the cells were
optically opaque (Fig. 4a), thus providing strong photoacoustic
contrasts. From SEM images, melanoma cells, as marked by the
arrows, have a typical size of 20–100 mm when they are fully
stretched (Fig. 4b) or form cell clusters (Fig. 4c). The coronal
(top view) and sagittal (side view) MAP images from PAM in
Fig. 4d clearly show the spatial distribution of cells in the scaffold,
penetrating the entire cell/scaffold construct with a thickness of
around 1.5 mm. Fig. 4e shows a 3D depiction of melanoma cells in
the scaffold. Individual cells or cell clusters could be identified
(black dots or patches) in both 2D and 3D images. This penetration
depth is much deeper than what LSM can achieve (0.3 mm)
when imaging scaffolds similarly seeded withmelanoma cells [65].
Serial sections were further mapped with a layer thickness of
60 mm in the examined volume non-invasively without the need
of physically slicing the scaffold (420–780 mmin depth, Fig. 5). The
images clearly showed that PAM can resolve the spatial distribu-
tion of cells in the bulk of a thick scaffold. In another demonstra-
tion, both the dynamic and stationary methods were used for
seeding and culturing cells in scaffolds, whichwere then evaluated
using PAM. For the dynamic method, the cells were uniformly
distributed throughout the 3D scaffold over the entire 14 days. For
the stationary method, the cells were mainly distributed at the
perimeter of the scaffold at 1 day post-seeding, whereas the dis-
tribution became uniform after 14 days because of cell migration,
indicating that PAM can readily distinguish different patterns of
cell distribution as well as cell migration.
In addition to qualitative imaging, it is even more challenging
to temporally monitor and quantify cell proliferation in a 3D
scaffold with relatively high spatial resolution. Fluorescence
microscopy may be useful for long-term monitor if the cells are
labeled with live-cell dyes [69], or with intrinsic fluorescent
proteins [70]. However, photobleaching of the fluorescent dyes
and proteins can be a problem, and cellmitosis can dilute the dyes
as well. Shallow penetration depth comprises another limitation.
By contrast, PAM is well-suited for chronologically monitoring
and quantifying cell proliferation in individual scaffolds by tak-
ing advantages of strong contrast and deep penetration. Mela-
noma cells were seeded into PLGA inverse opal scaffolds and non-
invasively imaged by AR-PAM at days 1, 3, 7 and 14 post-seeding.
Time-course coronal MAP PAM images clearly show the prolifera-
tion of melanoma cells inside the same scaffold (Fig. 6a). Photo-
acoustic volumetric data were further utilized to quantify the cell
numbers. The signal amplitude from the photoacoustic volu-
metric data was found to be linearly correlated with the number
of cells in the scaffold [65]. From the calibration curve, the average
cell numbers at days 1, 3, 7 and 14were calculated to be 4.9  104,
2.8  105, 3.4  105 and 2.7  105 per scaffold, respectively.
Fig. 6b plots the cell numbers calculated by PAM as a function72of time. The profile agreed well with the result from a parallel
analysis where cell proliferation was measured using the conven-
tional invasive 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT) assay.
MTT formazan stained cells in scaffolds
All cells can potentially be imaged directly by PAM at some
wavelengths because of their different intrinsic absorption con-
trasts with the background from absorption of such as melanin,
cytoplasm and nuclei. However, extrinsic contrast agents are
widely used to enhance image contrasts and achieve deeper pene-
tration depth. Several types of contrast agent, such as reporter gene
expression [71–74] and gold nanoparticles [75,26,76–79], have
been demonstrated for use with PAM imaging of cells. Another
simple method has recently been devised based on MTT formazan
for stable and non-toxic staining of various types of cells, allowing
PAM imaging in both 2D and 3D [80]. MTT is a water-soluble
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formazan in living cells [81,82]. The MTT assay has been widely
used to evaluate cell viability, metabolic activity, and prolifera-
tion. The suspension of MTT formazan crystals in phosphate
buffered saline shows strong absorption in the spectral region of
500–700 nm, with a peak at 650 nm. As a result, the MTT for-
mazan crystals formed inside living cells can be directly used to
remarkably enhance their contrast for PAM. This contrastmechan-
ism is general and applicable to essentially all types of metaboli-
cally active cells such as fibroblasts, stem cells, and tumor cells.
In a demonstration, we seeded fibroblasts in a PLGA inverse
opal scaffold and then stained the cells with MTT formazan. The
coronal and sagittal MAP PAM images could be used to resolve the
spatial distribution of fibroblasts in the scaffold with a penetration[(Figure_7)TD$FIG]
FIGURE 7
(a) MAP PAM image of fibroblasts cultured in an inverse opal scaffold, followed b
(c) MAP PAM image of fibroblasts cultured in an inverse opal scaffold filled with
and (d) an optical micrograph showing the same scaffold as in (c). As indicated
other. Scale bars in (a–d): 1 mm. (e) PAM chronological images of fibroblasts gro
surface) at 6 h, 3 days and 7 days; and (f) quantification of cell numbers in the s
biochemical assays. (g) PAM images showing cell invasion profile at days 1 and 7
quantification of average cell penetration depths in scaffolds with pore sizes of 2
Reprinted with permission from Ref. [80]. Copyright 2011 Wiley-VCH.depth over 1.5 mm (Fig. 7a, dark dots). The 3D distribution of cells
could be rendered from the volumetric PAM data (Fig. 7b). It was
further proven that MTT could also stain cells in a dense matrix
rather than the highly porous scaffolds. In this case, fibroblasts
were cultured in a PLGA inverse opal scaffold filled with cross-
linked alginate hydrogel. Again, the images (Fig. 7c) clearly
showed identifiable cells throughout the scaffold after incubating
withMTT solution. The features on the surface of the scaffold were
matched with those shown in the optical micrograph (Fig. 7d),
indicating good accuracy of PAM. Chronological PAM was further
employed to quantify the proliferation of cells. At 6 h, 3 days and
7 days post-seeding of fibroblasts, the scaffolds were incubated
with MTT and then imaged with AR-PAM (MAP images shown
in Fig. 7e). The integration of photoacoustic signal amplitudesy MTT staining for 3 h; (b) 3D rendering of the volumetric PAM data in (a);
cross-linked alginate hydrogel, followed by incubation with MTT for 4 h;
by arrows, the features in PAM and optical microscopy well matched each
wn in inverse opal scaffolds (MAPs in the 600–660 mm layers from the top
caffolds as determined by volumetric PAM data and parallel MTT
into inverse opal scaffolds with a pore size of 300 mm; and (h)
00 and 300 mm, respectively, as determined by PAM virtual biopsy.
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days 3 and 7 were normalized to what was obtained at 6 h. In
Fig. 7f, the curve clearly shows how the cells proliferated over time.
The proliferation profile derived from PAM matched what was
obtained from the traditional destructive MTT cell viability assay
based on the spectrophotometry method. The scope of the appli-
cation was further expanded to a cell invasion assay, in which
fibroblasts were induced to invade into PLGA inverse opal scaf-
foldswith twodifferent pore sizes of 200 and300 mm.As shownby
the sagittal MAP PAM images (Fig. 7g), by day 7, the cells had
invaded from the seeding side (bottomof the image) into approxi-
mately a half thickness of the scaffold with 300-mmpores. Fig. 7h
shows the quantification of average cell penetration depths in the
two types of scaffolds, where different rates and degrees of cell
invasion could be efficiently observed. Therefore, PAM can func-
tion as virtual biopsy to non-invasively monitor the interaction
between cells and scaffolds, unlike conventional histology meth-
ods, which require physical sectioning of the construct in a
destructive manner.[(Figure_8)TD$FIG]
FIGURE 8
Chronological OR-PAM and OCT images showing the vasculature and scaffold/tis
implanted in a mouse ear model. (a–c) MAP PAM images showing the developm
(d–f) The corresponding OCT MAP images showing the scaffold/tissue construct
show the surface of the scaffold more clearly. Arrowheads indicate examples of l
(g–i) Co-registered 3D depictions of the vasculature (red) and scaffold/tissue con
arrowheads indicate the growth of neovasculature into the pores of the scaffold.
Reprinted with permission from Ref. [84]. Copyright 2011 Mary Ann Liebert, Inc.
74Photoacoustic microscopy of neovascularization in
scaffolds in vivo
Angiogenesis is a crucial step in the process of natural wound
healing or tissue repairing [6]. It is also important in regenerative
medicine especially for the engineering of thick or highly vascu-
larized tissues such as liver and myocardium, to provide sufficient
supplies of nutrients and oxygen to cells residing in the bulk of a
scaffold [7,83]. Recently, PAM has been demonstrated for non-
invasive imaging and monitoring of the neovascularization pro-
cess in individual porous scaffolds in vivo up to 6 weeks post
implantation [84].
PLGA inverse opal scaffolds (pore size: 200 mm; dimensions:
3 mm  3 mm  1.5 mm) were implanted subcutaneously in the
ears of nude mice, and then monitored using a dual-modality OR-
PAM/OCT system [85] for 6 weeks. The dual-modality system was
able to simultaneously image and analyze the vasculature and the
scaffolds. As shown by the coronal MAP PAM images in Fig. 8a–c,
the density of blood vessels increased with time over the 6-week
period. Microvasculature down to the capillary level could besue construct for an inverse opal scaffold with a pore size of 200 mm
ent of blood vessels at 2, 4 and 6 weeks post-implantation, respectively.
. The signals from the skin layer were removed from all the OCT images to
ocal increase in pore size over time because of degradation of the scaffold.
struct (green) at 2, 4 and 6 weeks post-implantation, respectively. The
Scale bars: 500 mm.
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FIGURE 9
Chronological AR-PAM images revealing the development of neovasculature in an inverse opal scaffold with a pore size of 200 mm implanted in a mouse
ear model. (a–d) MAP images without removing the signals from the skin layer on top of the scaffold at 1, 2, 4 and 6 weeks post-implantation, respectively.
(e–h) Corresponding MAP images after removal of the signals from the skin layer on top of the scaffold. (i–l) The corresponding B-scan images at planes
marked by the green dashed lines in (a–d), respectively. The dotted square indicates the area where the scaffold resided.
Reprinted with permission from Ref. [84]. Copyright 2011 Mary Ann Liebert, Inc.
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shown by the MAP OCT images in Fig. 8d–f, collected simulta-
neously with PAM images, the position of the scaffold could also
be well resolved. The signals from the skin layer were removed
from all the OCT images to show the surface of the scaffold more
clearly. Some regions of the scaffold had slightly degraded over the
6-week period, leading to a local increase in pore size (indicated by
arrowheads). Fig. 8g–i shows co-registered 3D depictions of the
vasculature (in red) and the scaffold/tissue construct (in green).
The arrowheads indicate the growth of the neovasculature into the
pores of the scaffold.
Deeper penetration could be further achieved using AR-PAM. At
week 1, the scaffold region (indicated by the white dotted square)
could be clearly observed because of the absence of blood vessels
(Fig. 9a). The scaffold region could be better resolved in Fig. 9e after
removal of the signals from the skin (150 mm in thickness) using
a skin-removal algorithm [86]. As shown by Fig. 9b–d, the neo-
vasculature developed gradually over time, consistent with the
results from OR-PAM. These blood vessels not only grew on top of
the implanted scaffold but also penetrated into the bulk of the
scaffold (Fig. 9f–h, with removal of the signals from the skin). In
addition, B-scan images (Fig. 9, i–l) at the indicated positions
(green dotted lines in Fig. 9a–d) show increases both in photo-
acoustic amplitude and number of blood vessels in the central
regions, confirming the inward growth of the neovasculature into
the inner pores of the scaffold.
Quantifications of normalized vessel area as functions of time are
shown in Fig. 10a and b. The area of blood vessels at each time point
was normalized against that of the scaffolds with a pore size of80 mm at week 2. The PAM results show that the normalized vessel
areas for the scaffolds with a pore size of 200 mmwas 2.0–3.5 times
larger than those of the scaffolds with a pore size of 80 mm over a
period of 6 weeks, which correlated well with the conventional,
invasive histology analyseswhere complicated sectioning processes
are involved. The development of neovasculature close to the sur-
face (0–200 mm) of the scaffold was also examined using the PAM
data. In both types of scaffolds, there were vessels with large areas,
and the vessel areas were estimated to be1.9 times and3.7 times
larger than those in the central regionof the scaffoldswithpore sizes
of 200 mm and 80 mm, respectively (Fig. 10c). Similar results were
obtained by analyzing the histology data.
Future developments
PAT/PAM is expected to find broad applications in imaging 3D
scaffold-based samples for regenerative medicine. PAT can even
image objects in biological tissues as deep as 7 cm at the
expense of decreasing lateral resolution [23], which may be
sufficient to fit the ultimate goal of engineering tissues with large
volumes. Functional PAM can also be performed to derive other
important parameters (e.g. flow velocity, oxygen saturation, oxy-
gen partial pressure, and metabolicrate of oxygen) of the neo-
vasculature [87–90].
PAT/PAM still has multiple technical challenges. For high-speed
multi-contrast PAM based on spectroscopy, high-sensitivity acous-
tic arrays and high-repetition lasers with fast wavelength-tuning at
each scan position must be developed. Multiscale PAT bridges the
gap of a complex biological system between the microscopic and
macroscopic domains through consistent optical absorption75
RESEARCH Materials Today Volume 16, Number 3 March 2013
[(Figure_10)TD$FIG]
FIGURE 10
Comparison of histology analyses and PAM quantification. (a and b)
Normalized vessel area calculated from both PAM data and histology for
scaffolds with a pore size of (a) 200 mm and (b) 80 mm. (c) A comparison of
the blood vessel area in the scaffolds at planes close to the surface and in
the central region of the scaffolds 6 weeks post-implantation. S: surface; C:
center; His: histology. All the results were presented as mean  standard
error (n = 3).
Reprinted with permission from Ref. [84]. Copyright 2011 Mary Ann Liebert,
Inc.
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of switchable resolutions and penetration depths is of great interest
[91]. It is expected that further advancement of this fast-growing
imaging modality will find even broader applications for tissue
engineering and regenerative medicine, especially when thick scaf-
fold/tissue constructs are involved.
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